glp-1 medications side effects temporary or long-term Comparative safety and of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Your guide to GLP-1 side

The bulky A350 6.39b W and K351 6.40b A mutants almost abolished the maximal response ( E max ) of GLP-1R-mediated cAMP accumulation in presence of compound 2, while V332 5.62b A, K346 6.35b A, and L349 6.38b A mutants greatly elevated basal cAMP activities but significantly diminished the efficacy of the response upon stimulation by either compound 2 or GLP-1, suggesting these mutations affect the kink of TM6 required for receptor activation

patients should be counseled to report symptoms such as neck mass, dysphagia, or persistent hoarseness Contraindication : Personal or family history of MTC or MEN2 Gallbladder disease : Tirzepatide may increase risk of gallstones and cholecystitis Acute kidney injury : Dehydration from gastrointestinal adverse effects may impair renal function Pancreatitis : Patients should be counseled to report severe, persistent abdominal pain Niacin-specific safety concerns: Hepatotoxicity : Baseline liver function tests and monitoring during dose titration and periodically thereafter are recommended

If you experience persistent or worsening fatigue, discuss this with your clinicianit may warrant thyroid function reassessment

Jones et al., 2010)